Nearly 15 years after trying an experimental drug on children in Nigeria during a deadly meningitis epidemic, Pfizer Inc. is still battling the legal claims brought by the children’s families; the families are still waiting for some sort of compensation; and, the case is still bogged down in pretrial motions.
A status hearing was scheduled in U.S. District Court in Manhattan Friday, but has been postponed indefinitely, as Pfizer continues to insist that the case should be dismissed. Pfizer attorney Joseph Petrosinelli, of Williams & Connolly in Washington, D.C., said he couldn’t comment on an ongoing case.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]